Risk factor
Limited trading liquidity
Profitability factor
Very favourable analyst view
About
Hikal Limited, together with its subsidiaries, manufactures and sells various chemical intermediates, specialty chemicals, and active pharma ingredients to pharmaceutical, animal healthcare, biotech, crop protection, and specialty chemicals companies. It operates through two segments, Pharmaceuticals and Crop Protection. The Pharmaceuticals segment produces active pharmaceutical ingredient (APIs). The Crop Protection segment manufactures pesticides and herbicides. The...
Company Valuation
Considering past and projected metrics, the stock is neither 'expensive' nor 'cheap' compared to its peers. Specifically, the stock is 'expensive' on P/E, undervalued on
Target Price
The average target price of HIKAL.NS is 390 and suggests 83% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to inc
Buy
Sell